Literature DB >> 21384250

Serodiagnostic assays for celiac disease based on the open or closed conformation of the autoantigen, transglutaminase 2.

Katri Lindfors1, Outi Koskinen, Kalle Kurppa, Kaija Laurila, Pekka Collin, Katri Haimila, Jukka Partanen, Päivi Saavalainen, Markku Mäki, Katri Kaukinen.   

Abstract

The autoantigen of celiac disease, transglutaminase 2 (TG2), adopts an open conformation during enzymatic activation. We studied diagnostic accuracy of serodiagnostic assays using TG2 in its open and closed conformation as antigens in patients with diagnostic difficulties. The open TG2 antibody (TG2ab) test identified 93% of untreated celiac patients in contrast to 44%, 27%, and 68% detected by closed and conventional TG2ab and endomysial antibody (EmA) tests, respectively. The assay was able to detect 60% of non-responding celiac patients seronegative for conventional TG2ab and EmA. The titers of the open TG2abs were higher than those of the closed TG2abs. The serological test utilizing TG2 in an open conformation was more accurate than the other assays in finding active celiac disease even in patients having negative or borderline conventional celiac autoantibodies and in revealing poor dietary response non-invasively. It thus offers a promising tool in the diagnostics and follow-up of celiac disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21384250     DOI: 10.1007/s10875-011-9514-x

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  28 in total

1.  IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease.

Authors:  Katri Kaukinen; Satu Sulkanen; Markku Mäki; Pekka Collin
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-03       Impact factor: 2.566

2.  Anti-tissue transglutaminase antibodies in the follow-up of adult coeliac disease.

Authors:  C R Dipper; S Maitra; R Thomas; C A Lamb; A P C McLean-Tooke; R Ward; D Smith; G Spickett; J C Mansfield
Journal:  Aliment Pharmacol Ther       Date:  2009-05-12       Impact factor: 8.171

3.  Identification of tissue transglutaminase as the autoantigen of celiac disease.

Authors:  W Dieterich; T Ehnis; M Bauer; P Donner; U Volta; E O Riecken; D Schuppan
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

4.  Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet.

Authors:  Tamara Matysiak-Budnik; Georgia Malamut; Natacha Patey-Mariaud de Serre; Etienne Grosdidier; Sylvie Seguier; Nicole Brousse; Sophie Caillat-Zucman; Nadine Cerf-Bensussan; Jacques Schmitz; Christophe Cellier
Journal:  Gut       Date:  2007-02-15       Impact factor: 23.059

5.  Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study.

Authors:  Pekka Collin; Katri Kaukinen; Harald Vogelsang; Ilma Korponay-Szabó; Rudolf Sommer; Elisabeth Schreier; Umberto Volta; Alessandro Granito; Lorenza Veronesi; Françoise Mascart; Annick Ocmant; Anneli Ivarsson; Carina Lagerqvist; Annemarie Bürgin-Wolff; Faruk Hadziselimovic; Raoul I Furlano; Marc A Sidler; Chris J J Mulder; Marije S Goerres; M Luisa Mearin; Maarten K Ninaber; Eivind Gudmand-Høyer; Elisabetta Fabiani; Carlo Catassi; Helena Tidlund; Lisbeth Alainentalo; Markku Mäki
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-01       Impact factor: 2.566

6.  Biochemical and immuno-pathological aspects of tissue transglutaminase in coeliac disease.

Authors:  E Bodil Roth; Klas Sjöberg; Pål Stenberg
Journal:  Autoimmunity       Date:  2003-06       Impact factor: 2.815

7.  Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study.

Authors:  Kalle Kurppa; Pekka Collin; Mervi Viljamaa; Katri Haimila; Päivi Saavalainen; Jukka Partanen; Kaija Laurila; Heini Huhtala; Kaija Paasikivi; Markku Mäki; Katri Kaukinen
Journal:  Gastroenterology       Date:  2008-11-24       Impact factor: 22.682

8.  Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis.

Authors:  Umberto Volta; Alessandro Granito; Claudia Parisi; Angela Fabbri; Erica Fiorini; Maria Piscaglia; Francesco Tovoli; Valentina Grasso; Paolo Muratori; Georgios Pappas; Roberto De Giorgio
Journal:  J Clin Gastroenterol       Date:  2010-03       Impact factor: 3.062

9.  Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease.

Authors:  Matthew R Donaldson; Sean D Firth; Holly Wimpee; Kristin M Leiferman; John J Zone; Wyatt Horsley; Molly A O'Gorman; W Daniel Jackson; Susan L Neuhausen; Christopher M Hull; Linda S Book
Journal:  Clin Gastroenterol Hepatol       Date:  2007-04-11       Impact factor: 11.382

10.  Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study.

Authors:  Antonio Carroccio; Giustina Vitale; Lidia Di Prima; Nadia Chifari; Salvatore Napoli; Cristina La Russa; Gaspare Gulotta; Maurizio R Averna; Giuseppe Montalto; Serafino Mansueto; Alberto Notarbartolo
Journal:  Clin Chem       Date:  2002-09       Impact factor: 8.327

View more
  5 in total

1.  Open conformation tissue transglutaminase testing for celiac dietary assessment.

Authors:  Kumar Pallav; Daniel A Leffler; Michael Bennett; Sohaib Tariq; Hua Xu; Toufic Kabbani; Allan C Moss; Melinda Dennis; Ciaran P Kelly; Detlef Schuppan
Journal:  Dig Liver Dis       Date:  2012-01-18       Impact factor: 4.088

Review 2.  Screening for celiac disease in the general population and in high-risk groups.

Authors:  Jonas F Ludvigsson; Timothy R Card; Katri Kaukinen; Julio Bai; Fabiana Zingone; David S Sanders; Joseph A Murray
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

Review 3.  The adaptive immune response in celiac disease.

Authors:  Shuo-Wang Qiao; Rasmus Iversen; Melinda Ráki; Ludvig M Sollid
Journal:  Semin Immunopathol       Date:  2012-04-26       Impact factor: 9.623

4.  Is the Diagnosis of Celiac Disease Possible Without Intestinal Biopsy?

Authors:  Maha Shomaf; Mohammad Rashid; Dana Faydi; Ahmad Halawa
Journal:  Balkan Med J       Date:  2017-04-06       Impact factor: 2.021

5.  Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells.

Authors:  Rasmus Iversen; Roberto Di Niro; Jorunn Stamnaes; Knut E A Lundin; Patrick C Wilson; Ludvig M Sollid
Journal:  J Immunol       Date:  2013-05-20       Impact factor: 5.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.